A transposon screen identifies enhancement of NF-κB pathway as a mechanism of resistance to eribulin.
Breast Cancer
; 28(4): 884-895, 2021 Jul.
Article
in En
| MEDLINE
| ID: mdl-33616862
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Breast Neoplasms
/
NF-kappa B
/
Drug Resistance, Neoplasm
/
Tubulin Modulators
/
Furans
/
Ketones
Type of study:
Prognostic_studies
Limits:
Female
/
Humans
Language:
En
Journal:
Breast Cancer
Journal subject:
NEOPLASIAS
Year:
2021
Document type:
Article
Affiliation country:
Japón